Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens
Ernest H. S. Choy, Costantino Pitzalis, Alberto Cauli, J. A. Bijl, Allen Schantz, J. Woody, Gabrielle H. Kingsley, Gabriel S. PanayiVolume:
39
Year:
1996
Language:
english
Pages:
5
DOI:
10.1002/art.1780390107
File:
PDF, 398 KB
english, 1996